Related Experiment Video
Updated: Aug 29, 2026

Procedure and Key Optimization Strategies for an Automated Capillary Electrophoretic-based Immunoassay Method
Published on: September 10, 2017
Binding of p53-derived ligands to MDM2 induces a variety of long range conformational changes
Oliver Schon1, Assaf Friedler, Stefan Freund
1Cambridge University Chemical Laboratory and Cambridge Centre for Protein Engineering, MRC Centre, Hills Road, Cambridge CB2 2QH, UK.
Abstract:
We have used NMR to study the effects of peptide binding on the N-terminal p53-binding domain of human MDM2 (residues 25-109). There were changes in HSQC-chemical shifts throughout the domain on binding four different p53-derived peptide ligands that were significantly large to be indicative of global conformational changes. Large changes in chemical shift were observed in two main regions: the peptide-binding cleft that directly binds the p53 ligands; and the hinge regions connecting the beta-sheet and alpha-helical structures that form the binding cleft. These conformational changes reflect the adaptation of the cleft on binding peptide ligands that differ in length and amino acid composition. Different ligands may induce different conformational transitions in MDM2 that could be responsible for its function. The dynamic nature of MDM2 might be important in the design of anti-cancer drugs that are targeted to its p53-binding site.
Insights
Nuclear Magnetic Resonance (NMR) revealed significant conformational changes in the human MDM2 protein
Area of Science:
- Biochemistry
- Structural Biology
- Molecular Dynamics
Background:
- The human MDM2 protein plays a crucial role in regulating the p53 tumor suppressor.
- Understanding MDM2's interaction with p53 is vital for cancer therapy development.
- The N-terminal p53-binding domain of MDM2 is a key target for drug design.
Purpose of the Study:
- To investigate the conformational effects of peptide ligand binding on the human MDM2 N-terminal p53-binding domain.
- To elucidate the structural adaptations of MDM2 in response to varying p53-derived peptides.
Main Methods:
- Nuclear Magnetic Resonance (NMR) spectroscopy, specifically Heteronuclear Single Quantum Correlation (HSQC) chemical shift analysis.
- Studying the effects of four different p53-derived peptide ligands on MDM2 (residues 25-109).
Main Results:
- Peptide binding induced significant global conformational changes in the MDM2 domain, evidenced by widespread HSQC chemical shift perturbations.
- Major conformational changes were localized to the p53-binding cleft and the hinge regions connecting secondary structures.
- These changes indicate MDM2's adaptive response to the length and composition of bound p53 peptides.
Conclusions:
- MDM2 undergoes significant conformational adaptation upon binding to p53-derived peptides.
- The dynamic nature of MDM2's structure is crucial for its interaction with p53.
- These findings have implications for designing targeted anti-cancer drugs that modulate the MDM2-p53 interaction.
Related Concept Videos
Abnormal Proliferation
Covalently Linked Protein Regulators
These groups modify specific amino acids in a protein.
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
DNA Damage can Stall the Cell Cycle
DNA Damage Can Stall the Cell Cycle
Negative Regulator Molecules

